BURLINGTON, Mass., Jan. 7, 2016 /PRNewswire/ -- inVentiv Health, a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide, today announced that Chairman and Chief Executive Officer Michael Bell will present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco.
Mr. Bell’s presentation is scheduled to be delivered on Wednesday, January 13, 2016 at 8:30 a.m. PST at the Westin St. Francis Hotel.
About inVentiv Health
inVentiv Health is a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) help clients improve their performance to deliver much-needed therapies to market. With 14,000 employees providing services to clients in 70 countries, inVentiv Health designs best practices, processes and systems to enable clients to successfully navigate an increasingly complex environment. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv Health management team. For more information, visit inVentivHealth.com.
Logo - http://photos.prnewswire.com/prnh/20150805/255613LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/inventiv-health-ceo-to-present-at-jp-morgan-healthcare-conference-300201110.html
SOURCE inVentiv Health, Inc.
